Early imaging marker of progressing glioblastoma: a window of opportunity.
Na Tosha N GatsonShane P BrossYazmin OdiaGino J MongelluzzoYirui HuLaura LockardJesse J ManikowskiAnand MahadevanSyed A J KazmiMichel LacroixAndrew R CongerJoseph VadakaraLakshmi NayakT Linda ChiMinesh P MehtaVinay K PuduvalliPublished in: Journal of neuro-oncology (2020)
Implications of these data are far-reaching, potentially shifting paradigms for glioma treatment response assessment, altering timepoints for salvage therapeutic intervention, and reshaping glioma clinical trial design.